# SQK Company Overview 2026

## Positioning
SQK is a Quantum-AI-HPC platform company building validated, secure, and deployable computing systems for high-trust industries. The company leads with **QMedic** as its commercial product for CT/MRI-oriented workflows and uses **QTAU**, **Qukkos**, **QPINN**, **QPR**, and **HPC integration** to create measurable trust, hybrid execution, refinement, and domain scalability.

## Core Commercial Story
SQK is not presenting unrelated tools. The business story begins with **QMedic** in medical imaging and expands through reusable platform capabilities that also support scientific computing, industrial optimization, and hybrid HPC operations.

## Commercial Product Focus
### QMedic
QMedic is SQK’s lead commercial product. It packages reconstruction, QPR-assisted refinement, comparison, and quality governance into a workflow that can be adopted by hospitals, research hospitals, medical AI teams, and imaging software partners.

## Platform Capabilities Behind QMedic
- **QTAU**: benchmarking, reproducibility, scorecards, and reporting that create the trust layer.
- **Qukkos**: orchestration across classical, quantum, and HPC resources for deployable workflows.
- **QPINN**: physics-informed modeling for inverse problems, scientific simulation, and industrial optimization.
- **QPR**: refinement and reconstruction logic that strengthens imaging fidelity and guarded improvement.
- **HPC integration**: execution backbone for large-scale processing, simulation, and enterprise delivery.

## Domain Expansion Path
After healthcare, SQK can extend the same stack into:
- scientific computing and inverse problems
- digital twins and simulation-intensive engineering
- wind and energy optimization programs related to **QWIND**
- manufacturing and other industrial HPC workloads

## Business Model
- **QMedic**: paid pilots, research SaaS, API access, project deployments, then hospital and enterprise licensing.
- **QTAU**: validation services, benchmark reports, and annual benchmarking subscriptions.
- **Qukkos**: orchestration projects, workflow integration, and managed execution software.
- **QPINN / QPR**: modeling and refinement programs, optimization licenses, simulation modules, and co-development projects.
- **SuperQuantumStation**: education, developer access, and ecosystem funnel support.

## Revenue Structure
SQK targets a blended revenue model:
1. project and pilot revenue
2. recurring SaaS and API revenue
3. enterprise license and OEM revenue
4. validation and reporting subscriptions
5. industrial co-development and partner integration revenue

## Go-to-Market
1. Lead with QMedic in CT/MRI imaging workflows.
2. Attach QTAU reports and trust evidence.
3. Convert pilot and co-development credibility into paid programs.
4. Package repeatable modules such as APIs, reports, QPR services, and deployment connectors.
5. Expand toward enterprise licensing and partner-led distribution.

## Use of Investment
Capital is primarily allocated to:
- QMedic and QPR productization
- QTAU automation and evidence tooling
- HPC and orchestration engineering
- partner development and enterprise sales
- security, compliance, and regulatory preparation

## Investor Thesis
SQK combines a focused medical-imaging wedge with reusable Quantum-AI-HPC platform capabilities. QMedic creates near-term commercial traction, while QTAU, Qukkos, QPINN, QPR, and HPC integration increase long-term technical leverage, recurring revenue potential, and expansion into scientific and industrial domains.